Medtronic Stock Rises After Earnings. What Caught Investors’ Attention.

Medtronic posted fiscal second-quarter earnings and revenue that broadly beat analysts’ expectations and the company hiked its fiscal 2026 guidance. The medical technology company reported adjusted earnings of $1.36 a share, topping Wall Street’s calls for $1.31, while sales of $8.96 billion beat the $8.87 billion consensus among analysts polled by FactSet. The company recorded its strongest cardiovascular revenue growth in over a decade, excluding the pandemic.